AVTX
Price
$10.80
Change
-$0.75 (-6.49%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
151.91M
RLAY
Price
$5.17
Change
+$0.79 (+18.04%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
755.16M
40 days until earnings call
Interact to see
Advertisement

AVTX vs RLAY

Header iconAVTX vs RLAY Comparison
Open Charts AVTX vs RLAYBanner chart's image
Avalo Therapeutics
Price$10.80
Change-$0.75 (-6.49%)
Volume$11K
Capitalization151.91M
Relay Therapeutics
Price$5.17
Change+$0.79 (+18.04%)
Volume$66.74K
Capitalization755.16M
AVTX vs RLAY Comparison Chart in %
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. RLAY commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Hold and RLAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (AVTX: $10.80 vs. RLAY: $5.17)
Brand notoriety: AVTX and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 57% vs. RLAY: 103%
Market capitalization -- AVTX: $151.91M vs. RLAY: $755.16M
AVTX [@Biotechnology] is valued at $151.91M. RLAY’s [@Biotechnology] market capitalization is $755.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than AVTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 7 bullish TA indicator(s).

  • AVTX’s TA Score: 4 bullish, 5 bearish.
  • RLAY’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than AVTX.

Price Growth

AVTX (@Biotechnology) experienced а -8.71% price change this week, while RLAY (@Biotechnology) price change was +10.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

RLAY is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($755M) has a higher market cap than AVTX($152M). AVTX YTD gains are higher at: 55.451 vs. RLAY (25.485). AVTX has higher annual earnings (EBITDA): -59.78M vs. RLAY (-338.15M). RLAY has more cash in the bank: 657M vs. AVTX (113M). AVTX has less debt than RLAY: AVTX (679K) vs RLAY (34.2M). RLAY has higher revenues than AVTX: RLAY (8.36M) vs AVTX (441K).
AVTXRLAYAVTX / RLAY
Capitalization152M755M20%
EBITDA-59.78M-338.15M18%
Gain YTD55.45125.485218%
P/E Ratio1.77N/A-
Revenue441K8.36M5%
Total Cash113M657M17%
Total Debt679K34.2M2%
FUNDAMENTALS RATINGS
AVTX: Fundamental Ratings
AVTX
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVTXRLAY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
86%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHUSX31.05N/A
N/A
Alger Global Equity A
BBTLX16.37N/A
N/A
Bridge Builder Tax Managed Large Cap
LMOFX48.24N/A
N/A
Patient Opportunity FI
ALSCX7.38N/A
N/A
Alger Small Cap Growth B
BSGRX15.15N/A
N/A
BlackRock Advantage Small Cap Gr R

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
-0.43%
FGEN - AVTX
57%
Loosely correlated
-1.09%
LIANY - AVTX
39%
Loosely correlated
-15.43%
IMVT - AVTX
31%
Poorly correlated
+1.36%
RLAY - AVTX
31%
Poorly correlated
-3.10%
NRIX - AVTX
30%
Poorly correlated
-4.25%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with BDTX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+18.04%
BDTX - RLAY
53%
Loosely correlated
+9.16%
NRIX - RLAY
52%
Loosely correlated
+7.20%
IMNM - RLAY
52%
Loosely correlated
+14.13%
BEAM - RLAY
51%
Loosely correlated
-0.48%
RXRX - RLAY
51%
Loosely correlated
+2.05%
More